MRTO4

mRNA turnover protein 4 homolog · Q9UKD2 · MRTO4 on Sugi Atlas →

0 patent compounds predicted against MRTO4, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to MRTO4 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers PHASE2NOT_YET_RECRUITING
Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula PHASE2COMPLETED
Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders. PHASE1/PHASE2RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Allogeneic SCT for CML, TKI Failure After TKI Failure nanUNKNOWN
Molecular Mechanisms of Exercise Benefits to Insulin Resistant People nanCOMPLETED
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Na+ Channel mRNA Regulation in Heart Failure nanCOMPLETED
The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC nanUNKNOWN
Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation After Liver Transplantation nanCOMPLETED
The Role of Maspin in Colorectal Carcinoma, an Immunohistochemical Study nanNOT_YET_RECRUITING
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma nanACTIVE_NOT_RECRUITING
DNA Damage & Repair Proteins In Patients With Atherosclerotic Coronary Artery Disease nanCOMPLETED
miRNA as a Growth Plate Marker After GH nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
HE4 is a Beneficial Biomarker in Endometrial Cancer nanUNKNOWN
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Remote Ischemic Postconditioning Increases HIF-1α Plasma Levels and Improves Cardiac Markers After Cardiac Surgery nanCOMPLETED
Generating Intervals of Reference FFor Early Life Brain Biomarkers. nanRECRUITING
Quantification of GADD34 Expression in RA nanCOMPLETED
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Timisnar - Biomarkers Substudy (Timisnar-mirna) nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a MRTO4 binder may also engage these)

ProteinNameSimilarity
A4FV84 1.000 A4FV84 →
Q9D0I8 1.000 Q9D0I8 →
Q9H7B2 0.947 Q9H7B2 →
Q2YDN6 0.946 Q2YDN6 →
Q9JJ80 0.946 Q9JJ80 →
RPL11 Large ribosomal subunit protein uL5 0.942 landscape →
Q3T087 0.942 Q3T087 →
G1TUB8 0.941 G1TUB8 →
Q6EE31 0.937 Q6EE31 →
P42932 0.937 P42932 →
O80526 0.937 O80526 →
Q5R5F8 0.937 Q5R5F8 →
Q4R4U1 0.936 Q4R4U1 →
Q923S8 0.936 Q923S8 →
Q5R6E0 0.936 Q5R6E0 →
Q2QZ86 0.936 Q2QZ86 →
D2XV59 0.936 D2XV59 →
Q6QMZ8 0.936 Q6QMZ8 →
P62914 0.936 P62914 →
Q9CXW4 0.936 Q9CXW4 →
Q80Z29 0.936 Q80Z29 →
Q2QNG7 0.935 Q2QNG7 →
Q9NVE7 0.935 Q9NVE7 →
Q8BY71 0.935 Q8BY71 →
Q3ZCI9 0.935 Q3ZCI9 →
Q5RC11 0.935 Q5RC11 →
Q5F3X4 0.934 Q5F3X4 →
Q5XGS8 0.934 Q5XGS8 →
Q4R5J0 0.934 Q4R5J0 →
Q29205 0.934 Q29205 →